Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching Efavirenz to Rilpivirine for Neurocognitive Function in HIV
NCT03567304Phase 4Unknown
- Sponsor
- Chiang Mai University
- Start
- Jul 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rilpivirine in human immunodeficiency virus infection (HIV), sponsored by Chiang Mai University. Status: unknown.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03567304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03567304.